Myocardial regeneration therapy and structural pathology

Strategic objectives

  • The main objective is to study the safety, feasibility and efficacy of cell therapy in cardiovascular diseases, specifically in advanced chronic ischaemic heart disease and diabetic patients, and to study the process of vascular wall repair after coronary stent implantation.
  • Other objectives include the optimisation of the stem cell isolation process, the refinement of percutaneous cell administration techniques, the development of new cell therapy protocols, and the completion of an ongoing PhD thesis.
  • The aim is to consolidate this research group and extend its lines of research to other cardiovascular pathologies in particular, and to other fields of regenerative medicine in general.

Lines of research

  • Study of progenitor cell behaviour before heart diseases and clinical effects after percutaneous implantation
  • New percutaneous implantation devices for the treatment of advanced chronic heart diseases
  • Advances in percutaneous treatment of aortic valve disease
  • Advances in percutaneous treatment of mitral valve disease
  • Advances in the percutaneous treatment of tricuspid valvulopathy
  • Percutaneous devices to decrease bleeding risk in patients with chronic atrial fibrillation


Other members of the group

  • Luis Nombela Franco
  • María Aranzazu Ortega Pozzi
  • Mónica Pérez Serrano